The American Liver Foundation (ALF) has launched a toolkit — featuring a plush lion named Bili the Brave —…
Articles by Lindsey Shapiro, PhD
Abbvie has decided to permanently discontinue the marketing of antiviral treatments Exviera (dasabuvir) and Viekirax (ombitasvir/paritaprevir/ritonavir) for…
U.K. regulators have approved Iqirvo (elafibranor) for adults with primary biliary cholangitis (PBC) who fail to respond…
Two infusions of the investigational therapy CNP-104 safely reduced liver scarring (fibrosis) and led to beneficial changes in disease-related immune…
A researcher at the Virginia-Maryland College of Veterinary Medicine received a $2 million award from the National Institutes of Health…
Once daily treatment with oral ALG-055009 safely lowered levels of liver fat in people with metabolic dysfunction-associated steatohepatitis (MASH), a…
A U.S. Food and Drug Administration (FDA) advisory committee voted 10-1 that Ocaliva (obeticholic acid) doesn’t have a benefit-risk…
The American Liver Foundation (ALF) is granting its Spirit of Giving Family Award to a U.S. family for its…
Researchers have uncovered the structure of the protein complex that allows the hepatitis C virus (HCV) to infect human cells,…
Advanz Pharma has secured a temporary suspension of a decision by the European Commission (EC) to revoke conditional approval…